Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 20 Mar 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 20 Mar 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 13 Dec 2009 New trial record